Navigation Links
Improving Outcomes in the Treatment and Management of Metastatic Colorectal Cancer - International White Paper Launched at European Cancer Congress 2013
Date:9/28/2013

AMSTERDAM, Sept. 28, 2013 /PRNewswire/ -- The Angiogenesis Foundation released a white paper at the 2013 European Cancer Congress that addresses the needs, challenges, and proposed solutions for improving treatment of metastatic colorectal cancer (mCRC), the third most common cancer among men and the second most common among women worldwide. The white paper, "Improving Outcomes in the Treatment and Management of Metastatic Colorectal Cancer," is the result of the International Expert Summit for mCRC, convened by the Angiogenesis Foundation in Berlin, Germany, this past July, that gathered a global multidisciplinary group of leading experts on the field.

New targeted drugs that have been approved since 2004 have shifted oncologists' approach to treating mCRC, and the standard of care now involves treatments aimed at interfering with angiogenesis—new blood vessel growth—which supplies tumors with oxygen and nutrients. Antiangiogenic treatments have increased both the survival and quality of life for patients suffering from this disease. 

"With the advent of antiangiogenic therapy, metastatic CRC can now be approached as a cancer with multiple treatment options over time— choices that can improve a patient's quality of life. However, the benefit of these treatments has yet to be maximized and optimal care needs to be more accessible to all patients," commented Dr. William Li, President and Medical Director of the Angiogenesis Foundation.

This white paper addresses the current state of the field, identifies future goals and the barriers to those goals, and makes recommendations for advocacy leaders, oncologists, and the cancer community at large for improving patient outcomes worldwide. The white paper is being distributed at the European Cancer Congress at the Angiogenesis Foundation's advocacy booth, and can be downloaded at www.scienceofcrc.org/mCRC-globalwhitepaper.

The Angiogenesis Foundation (www.angio.org) is a nonprofit organization based in Cambridge, MA, USA that works with multiple stakeholders and leads international programs to improve health through treatments based on angiogenesis, the process of new blood vessel growth.


'/>"/>
SOURCE The Angiogenesis Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. 9th EUGMS Congress in Venice, Italy: Improving Outcomes of Geriatric Medicine
2. Mobile Health (mHealth) - Enhancing Healthcare and Improving Clinical Outcomes
3. First Large-Scale Population-Based Study in the U.S. Shows Hologics 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection
4. B. Braun Committed To Improving Patient Safety
5. New Interim Analysis From Observational Study Suggests That Delivery Of Insulin Via Valeritas V-Go Shows Promise In Improving Glycemic Control For Patients With Type 2 Diabetes
6. Treatment Adherence Emerging as Critical Theme in Improving Quality and Cost of US Healthcare
7. Contract Manufacturing Organizations to 2018 - Cost Advantages and Improving Quality Standards Build Confidence and Encourage Foreign Investment in Asian CMOs
8. Oncologists in the United States and Europe Indicate that Novel Chemotherapies Hold the Most Near-Term Promise for Improving Outcomes in Soft Tissue Sarcoma
9. Biometrics Limits Abuse while Improving Convenience
10. GlaxoSmithKline advances multi-city discussion focused on improving the health of US communities
11. Mt. Airy Hospital Selects Sound Physicians - Leading Hospitalist Organization Focuses on Improving Quality and Reducing Cost of Inpatient Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , Belgium , June 24, ... VNRX), today announced the appointment of Dr. ... Directors as a Non-Executive Director, effective June 23, ... Audit, Compensation and Nominations and Governance Committees.  As ... Futcher will provide independent expertise and strategic counsel ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... their offering. The current ... environment for MedImmune to enter. The US ageing population creates ... drive considerable growth for effective anti-influenza medications. The introduction of ... but development is still in its infancy. ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented ... in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, ...
Breaking Medicine News(10 mins):